Sign in
4

Changes in Ownership

Climb Bio, Inc. Filed Acc 0001193125-26-394357

Director sold 100,000 shares at $13.67 ($1,366,820)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Thomas Stephen Basil · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-09-15 Sale : show line 1 in the form 10b5-1 −100,000 $13.67 $1,366,820 467,969 D
Open-market sales · 100,000 sh · avg $13.67 · $1,366,820
Loading xslF345X06/ownership.xml…